| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.001 |